Ocular Cicatricial Pemphigoid

  • Ahmed Muna
  • C. Stephen Foster
Part of the Essentials in Ophthalmology book series (ESSENTIALS)


Amniotic Membrane Bullous Pemphigoid Meibomian Gland Penetrate Keratoplasty Corneal Neovascularization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ahmed AR, Foster S, Zaltas M, et al. (1991) Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid. Proc Natl Acad Sci U S A 88:11579–11582PubMedGoogle Scholar
  2. 2.
    Ahmed AR, Konqui A, Park MS, Tiwari JL, Terasaki PI (1984) DR antigens in bullous pemphigoid. Arch Dermatol 120:795CrossRefPubMedGoogle Scholar
  3. 3.
    Dantzig PI (1974) Immunosuppressive and cytotoxic drugs in dermatology. Arch Dermatol 110:393–406CrossRefPubMedGoogle Scholar
  4. 4.
    De Rotth A (1940) Plastic repair of conjunctival defects with fetal membranes. Arch Ophthalmol 23:522–525Google Scholar
  5. 5.
    Dohlman CH, Terada H (1998) Keratoprosthesis in pemphigoid and Stevens-Johnson syndrome. Adv Exp Med Biol 438:1021–1025PubMedGoogle Scholar
  6. 6.
    Donnenfeld ED, Perry HD, Wallerstein A, et al. (1999) Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology 106:72–78CrossRefPubMedGoogle Scholar
  7. 7.
    Elder MJ, Leonard J, Dart JK (1996) Sulphapyridine — a new agent for the treatment of ocular cicatricial pemphigoid. Br J Ophthalmol 80:549–552PubMedGoogle Scholar
  8. 8.
    Fern AI, Jay JL, Young H, MacKie R (1992) Dapsone therapy for the acute inflammatory phase of ocular pemphigoid. Br J Ophthalmol 76:332–335PubMedGoogle Scholar
  9. 9.
    Foster CS (1986) Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84:527–663PubMedGoogle Scholar
  10. 10.
    Foster CS (1993) Immunologic disorders of the conjunctiva, cornea, and sclera. In: Albert DM, Jakobiec FA (eds) Principles and practice of ophthalmology, vol 1. Philadelphia, Saunders, pp 196–199Google Scholar
  11. 11.
    Foster CS, Dutt JE, Rice BA, Kupferman AE, Lane L (1994) Conjunctival epithelial basement membrane zone immunohistology: normal and inflamed conjunctiva. Int Ophthalmol Clin 34:209–214PubMedGoogle Scholar
  12. 12.
    Foster CS, Wilson LA, Ekins MB (1982) Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 89:340–353PubMedGoogle Scholar
  13. 13.
    Fujimoto W, Toi Y, Okazaki F, et al. (1999) Antiepiligrin cicatricial pemphigoid with IgG autoantibodies to the beta and gamma subunits of laminin 5. J Am Acad Dermatol 40:637–639PubMedGoogle Scholar
  14. 14.
    Hirst LW, Werblin T, Novak M et al. (1982) Druginduced cicatrizing conjunctivitis simulating ocular pemphigoid. Cornea 1:121Google Scholar
  15. 15.
    Kanitakis J, Zambruno G, Vassileva S, Giannetti A, Thivolet J (1992) Alpha-6 (CD 49f) integrin expression in genetic and acquired bullous skin diseases. A comparison of its distribution with bullous pemphigoid antigen. J Cutan Pathol 19:376–384PubMedGoogle Scholar
  16. 16.
    Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB (1995) Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 105:543–548CrossRefPubMedGoogle Scholar
  17. 17.
    Lee SJ, Li Z, Sherman B, Foster CS (1993) Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 34:3522–3525PubMedGoogle Scholar
  18. 18.
    Letko E, Bhol K, Foster SC, Ahmed RA (2000) Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study. Curr Eye Res 21:646–654CrossRefPubMedGoogle Scholar
  19. 19.
    Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS (2002) The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology 109:111–118CrossRefPubMedGoogle Scholar
  20. 20.
    Mondino BJ, Brown SI (1981) Ocular cicatricial pemphigoid. Ophthalmology 88:95–100PubMedGoogle Scholar
  21. 21.
    Mondino BJ, Brown SI (1983) Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 96:453–459PubMedGoogle Scholar
  22. 22.
    Mondino BJ, Brown SI, Lempert S, Jenkins MS (1979) The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophthalmology 86:543–555PubMedGoogle Scholar
  23. 23.
    Mondino BJ, Ross AN, Rabin BS, Brown SI (1977) Autoimmune phenomena in ocular cicatricial pemphigoid. Am J Ophthalmol 83:443–450PubMedGoogle Scholar
  24. 24.
    Neumann R, Tauber J, Foster CS (1991) Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology 98:858–862PubMedGoogle Scholar
  25. 25.
    Papaliodis GN, Chu D, Foster CS (2003) Treatment of ocular inflammatory disorders with daclizumab. Ophthalmology 110:786–789PubMedGoogle Scholar
  26. 26.
    Pouliquen Y, Patey A, Foster CS, Goichot L, Savoldelli M (1986) Drug-induced cicatricial pemphigoid affecting the conjunctiva. Light and electron microscopic features. Ophthalmology 93:775–783PubMedGoogle Scholar
  27. 27.
    Tugal-Tutkun I, Akova YA, Foster CS (1995) Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 102:576–585PubMedGoogle Scholar
  28. 28.
    Yancey KB, Kirtschig G, Yee C, Lazarova Z (1995) Studies of patients with anti-epiligrin cicatricial pemphigoid. J Dermatol 22:829–835PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Ahmed Muna
  • C. Stephen Foster

There are no affiliations available

Personalised recommendations